Published in J Hepatol on May 01, 2005
Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort. Aliment Pharmacol Ther (2014) 3.98
A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis. Gastroenterology (2008) 1.65
Alcoholic hepatitis: current challenges and future directions. Clin Gastroenterol Hepatol (2013) 1.25
Current concepts and controversies in the treatment of alcoholic hepatitis. World J Gastroenterol (2006) 1.17
Alcoholic liver disease. World J Hepatol (2012) 1.16
Alcoholic hepatitis 2010: a clinician's guide to diagnosis and therapy. World J Gastroenterol (2010) 1.13
The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids. Gut (2007) 1.11
Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial. PLoS One (2013) 0.99
Early liver biopsy, intraparenchymal cholestasis, and prognosis in patients with alcoholic steatohepatitis. BMC Gastroenterol (2011) 0.95
Predictive factors for rebleeding and death in alcoholic cirrhotic patients with acute variceal bleeding: a multivariate analysis. World J Surg (2009) 0.93
Alcoholic hepatitis: a comprehensive review of pathogenesis and treatment. World J Gastroenterol (2014) 0.92
Prevalence of septic events, type 1 hepatorenal syndrome, and mortality in severe alcoholic hepatitis and utility of discriminant function and MELD score in predicting these adverse events. Dig Dis Sci (2006) 0.92
Organ allocation for chronic liver disease: model for end-stage liver disease and beyond. Curr Opin Gastroenterol (2010) 0.92
Model for End-stage Liver Disease. J Clin Exp Hepatol (2012) 0.92
Predicting utility of a model for end stage liver disease in alcoholic liver disease. World J Gastroenterol (2006) 0.91
KASL clinical practice guidelines: management of alcoholic liver disease. Clin Mol Hepatol (2013) 0.87
Alkaline phosphatase: the next independent predictor of the poor 90-day outcome in alcoholic hepatitis. Biomed Res Int (2013) 0.86
The utility of scoring systems in predicting early and late mortality in alcoholic hepatitis: whose score is it anyway? Int J Hepatol (2012) 0.86
Assessment of the Model for End-stage Liver Disease (MELD) Score in Predicting Prognosis of Patients with Alcoholic Hepatitis. J Clin Exp Hepatol (2014) 0.82
Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine. Hepat Med (2013) 0.82
Validation of a model to estimate survival in ambulatory patients with hepatocellular carcinoma: a single-centre cohort study. Liver Int (2014) 0.82
Prediction of survival after liver transplantation for chronic severe hepatitis B based on preoperative prognostic scores: a single center's experience in China. World J Surg (2009) 0.81
Why the C-statistic is not informative to evaluate early warning scores and what metrics to use. Crit Care (2015) 0.80
Diagnosis of alcoholic liver disease. World J Gastroenterol (2014) 0.79
Comparison of the Child-Turcotte-Pugh classification and the model for end-stage liver disease score as predictors of the severity of the systemic inflammatory response in patients undergoing living-donor liver transplantation. J Korean Med Sci (2011) 0.78
Diagnosis and Treatment of Alcoholic Hepatitis: A Systematic Review. Alcohol Clin Exp Res (2016) 0.77
Hepatitis C as a prognostic indicator among noncirrhotic patients hospitalized with alcoholic hepatitis. Can J Gastroenterol (2013) 0.77
Prognostic evaluation of alcoholic hepatitis. J Hepatol (2005) 0.76
Treatment of decompensated alcoholic liver disease. Int J Hepatol (2011) 0.76
Alcoholic hepatitis and HCV interactions in the modulation of liver disease. J Viral Hepat (2015) 0.76
Corticosteroids Versus Pentoxifylline for Severe Alcoholic Hepatitis: A Sequential Analysis of Randomized Controlled Trials. J Clin Gastroenterol (2016) 0.75
Model for end-stage liver disease-Na score or Maddrey discrimination function index, which score is best? World J Hepatol (2015) 0.75
Pathophysiology and Management of Alcoholic Liver Disease: Update 2016. Gut Liver (2017) 0.75
Practical Concerns and Controversies in the Management of Alcoholic Hepatitis. Gastroenterol Hepatol (N Y) (2016) 0.75
Risk factors for mortality in patients with alcoholic hepatitis and assessment of prognostic models: A population-based study. Can J Gastroenterol Hepatol (2015) 0.75
Emerging concepts in alcoholic hepatitis. World J Hepatol (2017) 0.75
Comparison of four models for end-stage liver disease in evaluating the prognosis of cirrhosis. World J Gastroenterol (2008) 0.75
An Evaluation of the Usefulness of Extracorporeal Liver Support Techniques in Patients Hospitalized in the ICU for Severe Liver Dysfunction Secondary to Alcoholic Liver Disease. Hepat Mon (2016) 0.75
Assessment of scoring systems for acute-on-chronic liver failure at predicting short-term mortality in patients with alcoholic hepatitis. World J Gastroenterol (2016) 0.75
Prognostic models for alcoholic hepatitis. Biomark Res (2015) 0.75
Acute-on-chronic liver failure: recent update. J Biomed Res (2017) 0.75
Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection. Am J Gastroenterol (2005) 3.09
Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma. Hepatology (2015) 2.81
Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy. Hepatology (2010) 2.53
Severe intraoperative hyperglycemia is independently associated with surgical site infection after liver transplantation. Transplantation (2009) 1.65
Predictors of hyperkalemia in the prereperfusion, early postreperfusion, and late postreperfusion periods during adult liver transplantation. Anesth Analg (2007) 1.57
Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma. Am J Gastroenterol (2004) 1.32
Spontaneous bacterial peritonitis. Dig Dis (2005) 1.27
Overweight and obesity, hepatic steatosis, and progression of chronic hepatitis C: a retrospective study on a large cohort of patients in the United States. J Hepatol (2004) 1.20
Octreotide/Midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome. Dig Dis Sci (2007) 1.13
Alcoholic hepatitis 2010: a clinician's guide to diagnosis and therapy. World J Gastroenterol (2010) 1.13
Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells. Am J Transl Res (2010) 1.10
In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells. Clin Cancer Res (2005) 1.04
Effects and mechanisms of silibinin on human hepatoma cell lines. World J Gastroenterol (2007) 1.02
Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice? J Clin Gastroenterol (2008) 0.99
Nephrogenic fibrosing dermopathy after liver transplantation successfully treated with plasmapheresis. Am J Dermatopathol (2003) 0.99
Rapid diagnosis of spontaneous bacterial peritonitis with leukocyte esterase reagent strips in a European and in an American center. J Gastroenterol Hepatol (2005) 0.98
Hepatitis C virus (HCV) infection and hepatic steatosis. Int J Med Sci (2006) 0.98
Nitric oxide in ascitic fluid is an independent predictor of the development of renal impairment in patients with cirrhosis and spontaneous bacterial peritonitis. Eur J Gastroenterol Hepatol (2004) 0.97
Preoperative characteristics and intraoperative transfusion and vasopressor requirements in patients with low vs. high MELD scores. Liver Transpl (2006) 0.97
Recurrent massive steatosis with liver herniation following transplantation. Liver Transpl (2004) 0.96
Factors associated with hepatic fibrosis in patients with chronic hepatitis C: a retrospective study of a large cohort of U.S. patients. J Clin Gastroenterol (2009) 0.96
Long-term therapy with nucleoside/nucleotide analogues for chronic hepatitis B in Asian patients. Antivir Ther (2012) 0.95
High intratumoral metastasis-associated in colon cancer-1 expression predicts poor outcomes of cryoablation therapy for advanced hepatocellular carcinoma. J Transl Med (2013) 0.94
Clinical presentation of hepatocellular carcinoma (HCC) in Asian-Americans versus non-Asian-Americans. J Immigr Minor Health (2011) 0.93
Postliver transplant acute renal injury and failure by the RIFLE criteria in patients with normal pretransplant serum creatinine concentrations: a matched study. Transplantation (2011) 0.88
Choosing the location for non-image guided abdominal paracentesis. Liver Int (2005) 0.88
Update on rescue therapies in patients with lamivudine-resistant chronic hepatitis B. Drug Des Devel Ther (2013) 0.87
Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice. World J Gastroenterol (2009) 0.87
Fatal spontaneous gallbladder variceal bleeding in a patient with alcoholic cirrhosis. Dig Dis Sci (2002) 0.87
Prevalence and presentation of hepatitis B and C virus (HBV and HCV) infection in Vietnamese Americans via serial community serologic testing. J Immigr Minor Health (2015) 0.86
Usefulness of serum N-terminal-ProBNP in distinguishing ascites due to cirrhosis from ascites due to heart failure. J Clin Gastroenterol (2010) 0.86
Insulin therapy in divided doses coupled with blood transfusion versus large bolus doses in patients at high risk for hyperkalemia during liver transplantation. J Cardiothorac Vasc Anesth (2009) 0.85
Is albumin infusion necessary after large volume paracentesis? Liver Int (2009) 0.83
Strips and tubes: improving the diagnosis of spontaneous bacterial peritonitis. Hepatology (2003) 0.82
Model for end-stage liver disease (MELD) exception for ascites. Liver Transpl (2006) 0.81
Clinical presentation of chronic hepatitis C in patients with end-stage renal disease and on hemodialysis versus those with normal renal function. Am J Gastroenterol (2005) 0.81
Improvement in liver histology among Asian patients with chronic hepatitis B after long-term treatment with entecavir. Liver Int (2013) 0.79
A practical approach to managing patients with HCV infection. Int J Med Sci (2006) 0.79
Clinical presentation and disease phases of chronic hepatitis B using conventional versus modified ALT criteria in Asian Americans. Dig Dis Sci (2014) 0.78
Current hepatitis B treatment guidelines and future research directions. Front Med (2014) 0.78
The clinical presentation of chronic hepatitis B virus infection in Asian Americans: a single center retrospective study. J Clin Gastroenterol (2010) 0.78
Boceprevir plus peginterferon α-2b/ribavirin in chronic hepatitis C genotype 1: impact of baseline viral load on sustained virologic response. J Clin Gastroenterol (2014) 0.77
A pill a day can improve survival in patients with advanced cirrhosis. Gastroenterology (2007) 0.77
Care coordination for patients with cirrhosis: a "win-win" solution for patients, caregivers, providers, and healthcare expenditures. J Hepatol (2013) 0.77
Changing flora of bacterial infections in patients with cirrhosis. Liver Int (2010) 0.77
The evolution of ascitic fluid analysis in the diagnosis of spontaneous bacterial peritonitis. Am J Gastroenterol (2003) 0.77
In-vivo effects and mechanisms of celecoxib-reduced growth of cyclooxygenase-2 (COX-2)-expressing versus COX-2-deleted human HCC xenografts in nude mice. Anticancer Drugs (2008) 0.76
Charcoal-based hemodiabsorption liver support for episodic type C hepatic encephalopathy. Am J Gastroenterol (2003) 0.76
Intraoperative hypokalemia in pediatric liver transplantation: incidence and risk factors. Anesth Analg (2006) 0.76
High rates of viral suppression after long-term entecavir treatment of Asian patients with hepatitis B e antigen-positive chronic hepatitis B. Clin Gastroenterol Hepatol (2012) 0.75
Protective effect of an improved immunization practice of mother-to-infant transmission of hepatitis B virus and risk factors associated with immunoprophylaxis failure. Medicine (Baltimore) (2016) 0.75
Role of plasma BNP in patients with ascites: advantages and pitfalls. Hepatology (2014) 0.75
Guest editor's editorial: Advances in managing hepatitis C virus (HCV) infection (A special issue). Int J Med Sci (2006) 0.75
Defining a Patient Population With Cirrhosis: An Automated Algorithm With Natural Language Processing. J Clin Gastroenterol (2016) 0.75
A pilot study of an alcoholic liver disease recurrence prevention education program in hospitalized patients with advanced liver disease. Addict Behav (2005) 0.75
New perspective on the natural course of chronic HBV infection. Front Med (2014) 0.75
Hepatobiliary manifestations of gastrointestinal and nutritional disorders. Clin Liver Dis (2011) 0.75
Acute phase proteins in patients with cirrhosis. Liver Int (2012) 0.75
Alcoholic cirrhosis-associated hepatorenal syndrome treated with vasoactive agents. Nat Clin Pract Nephrol (2006) 0.75
Formal heparin anticoagulation protocol improves safety of charcoal-based liver-assist treatments. ASAIO J (2006) 0.75
Preface. Hepatobiliary manifestations of systemic diseases. Clin Liver Dis (2011) 0.75